Dergiler / Turkish Journal of Internal Medicine / 2020 / Cilt: 2 - Sayı: 1

Uric acid levels and clearance in chronic kidney disease patients

Sayfa
19–21
Yayın Tarihi
2020-01-29
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

There is no difference in uric acid clearance in PD and HD patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: Uric acid levels increase in chronic renal failure especially due to protein metabolism.
📊
Temel Bulgular & Veri:Results: The mean ages of PD and HD patients were 56.77 ±13.58 and 57.25 ± 16.45 years, respectively (p=0.864).
💡
Sonuç & Katkı:There is no difference in uric acid clearance in PD and HD patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Hemodialysis · peritoneal dialysis · uric acid

Abstract

Aim: Uric acid levels increase in chronic renal failure especially due to protein metabolism. In this study, we aimed to compare uric acid clearance who are also nephrotoxic in patients with end-stage renal disease. Methods: Sixty-one chronic peritoneal dialysis (PD) patients and fifty-one chronic hemodialysis (HD) patients included in the study. Duration of PD and HD, uric acid levels, age and gender of the patients evaluated. Uric acid levels in PD patients and HD patients compared. Results: The mean ages of PD and HD patients were 56.77 ±13.58 and 57.25 ± 16.45 years, respectively (p=0.864). The number of male patients was more in the PD group and female in the HD group (p=0.959). The duration of dialysis was 3.25 in PD, 3.75 in HD (p=0.925). The mean uric acid levels were 5.54 ± 1.13 mg/dL in PD patients, and 5.76 ±1.52 mg/dL in HD patients (p=0.389). Conclusion: Dialysis is used to remove toxins in end-stage renal disease. Uric acid levels may be elevated in patients with end-stage renal disease. There is no difference in uric acid clearance in PD and HD patients.

🔖

Bu Makaleye Atıf Yap

USTA, M., AYAR, Y. (2020). Uric acid levels and clearance in chronic kidney disease patients. Turkish Journal of Internal Medicine, Cilt: 2 - Sayı: 1, 19–21. https://ajindex.com/articles/809132

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Chonchol M, Shlipak MG, Katz R, et al.Relationship of uric acid whit progretion of kidney diseasre. Am J Kidney Dis 2007
  2. Harrison R. Structure and function of xanthine oxidoreductase: where are we now? Free Biol Med. 2002
  3. Sautin YY, Johnson RJ. Uric: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008
  4. Park C,Obi Y, Streja E, Rhee CM, Catabay CJ, Vaziri ND, Kovesdy CP, Kalantar- Zadeh K. Serum uric, protein intake and mortality in hemodialysis patients. Nephrol Dial Transplant. 2017
  5. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J,Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera – Acosta J, Mazzali M.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003
  6. Shankar A, Klein BE, Nieto FJ, Klein R. Association between serum uric acid level and peripheral arterial disease. Atherosclerosis. 2008
  7. Jonasson T, Ohlin AK, Gottsater A, Hultberg B, Ohlin H. Plasma homocysteine and markers for axidative stress and inflammation in patients wits coronary artery disease—a prospective randomized study of vitamin supplementation. Clin Chem Lab Med. 2005
  8. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovasküler risk. N Engl J Med. 2008
  9. Bandaru P, Shankar A, Association between serum uric acid levels and diabetes melllitus. Int Endocrinol.2011
  10. 604715 10- Feig DI. Uric acid: a novel mediator and marker of risk in choronic kidney disease? Curr Opin Nephrol Hypertens. 2009
  11. Petreski T, Bevc S, Ekart R, Hojs R. Hyperuricemia and long-term survival in patients with chronic kidney disease undergoing hemodialysis. Clin Nephrol. 2017
  12. Latif W, Karaboyas A, Tong L, Winchester JF, Arrington CJ, Pisoni RL, Marshall MR, Kleophas W, Levin NW, Sen A, et al. Uric acid levels and all-cause and cardivascular moratlity in the hemodialysis population. Clin J Am Soc Nephrol.2011
  13. Beberashvili I, Erlich A, Azar A, Sinuani I, Feldman L, Gorelik O, Stav K, Efrati S. Longitudinal study of serum uric nutritional status, and mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2016
  14. 11(6):1015-23. 14- Hsu SP, Pai MF, Peng YS, Chiang CK, Ho Tl, Hung KY. Serum uric acid levels show a’J-shaped’ association with all-cause mortality in hemodialysis patients. Nephrol Dial Transplant.2004
  15. Feng S, Jiang L, Shi Y, Shen H, Shi